Sigma Healthcare has dropped legal action against Chemist Warehouse

Peter Macdiarmid/Getty Images

Sigma Healthcare has dropped legal action against Australian pharmacy chain Chemist Warehouse in favour of a negotiated settlement over a disputed wholesale supply agreement.

A short time ago, Sigma shares were up 8.7% to $0.935. Sigma shares fell in May by more than a quarter when the company announced the dispute.

Legal proceedings started in May after the privately-owned My Chemist/Chemist Warehouse Group, said to have national sales of about $2.7 billion, indicated it was going to source products from another wholesaler.

Sigma, which owns the Amcal and Guardian brands, maintains that My Chemist/Chemist Warehouse Group, under an agreement running to June 2019, is not entitled to acquire products from another wholesaler.

However, Sigma released a statement today saying it had entered a formal negotiation to seek a commercial resolution to the dispute.

“If a commercial resolution is not reached the parties have agreed to confidential and binding mediation and arbitration,” Sigma said.

“As a result of these developments, Sigma will now discontinue legal proceedings.”

Sigma has estimated that the dispute could cut earnings by between $5 million and $10 million a year.

And the company has said underlying EBIT (earnings before interest and taxes) this financial year could be up to 5% below last year.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.